Johnson GV - Search Results

1

Vena cava and aortic smooth muscle cells express transglutaminases 1 and 4 in addition to transglutaminase 2.

Johnson KB, Petersen-Jones H, Thompson JM, Hitomi K, Itoh M, Bakker EN, Johnson GV, Colak G, Watts SW. Johnson KB, et al. Among authors: johnson gv. Am J Physiol Heart Circ Physiol. 2012 Apr 1;302(7):H1355-66. doi: 10.1152/ajpheart.00918.2011. Epub 2012 Feb 3. Am J Physiol Heart Circ Physiol. 2012. PMID: 22307675 Free PMC article.

2

Complete transglutaminase 2 ablation results in reduced stroke volumes and astrocytes that exhibit increased survival in response to ischemia.

Colak G, Johnson GV. Colak G, et al. Among authors: johnson gv. Neurobiol Dis. 2012 Mar;45(3):1042-50. doi: 10.1016/j.nbd.2011.12.023. Epub 2011 Dec 14. Neurobiol Dis. 2012. PMID: 22198379 Free PMC article.

3

Cytosolic guanine nucledotide binding deficient form of transglutaminase 2 (R580a) potentiates cell death in oxygen glucose deprivation.

Colak G, Keillor JW, Johnson GV. Colak G, et al. Among authors: johnson gv. PLoS One. 2011 Jan 31;6(1):e16665. doi: 10.1371/journal.pone.0016665. PLoS One. 2011. PMID: 21304968 Free PMC article.

4

Transglutaminase 2: a molecular Swiss army knife.

Gundemir S, Colak G, Tucholski J, Johnson GV. Gundemir S, et al. Among authors: johnson gv. Biochim Biophys Acta. 2012 Feb;1823(2):406-19. doi: 10.1016/j.bbamcr.2011.09.012. Epub 2011 Oct 10. Biochim Biophys Acta. 2012. PMID: 22015769 Free PMC article. Review.

5

Transglutaminase 2 protects against ischemic stroke.

Filiano AJ, Tucholski J, Dolan PJ, Colak G, Johnson GV. Filiano AJ, et al. Among authors: johnson gv. Neurobiol Dis. 2010 Sep;39(3):334-43. doi: 10.1016/j.nbd.2010.04.018. Epub 2010 May 6. Neurobiol Dis. 2010. PMID: 20451610 Free PMC article.

6

The application of permanent middle cerebral artery ligation in the mouse.

Colak G, Filiano AJ, Johnson GV. Colak G, et al. Among authors: johnson gv. J Vis Exp. 2011 Jul 25;(53):3039. doi: 10.3791/3039. J Vis Exp. 2011. PMID: 21808231 Free PMC article.

7

Transglutaminase 2 facilitates or ameliorates HIF signaling and ischemic cell death depending on its conformation and localization.

Gundemir S, Colak G, Feola J, Blouin R, Johnson GV. Gundemir S, et al. Among authors: johnson gv. Biochim Biophys Acta. 2013 Jan;1833(1):1-10. doi: 10.1016/j.bbamcr.2012.10.011. Epub 2012 Oct 17. Biochim Biophys Acta. 2013. PMID: 23085038 Free PMC article.

8

Transglutaminase regulation of cell function.

Eckert RL, Kaartinen MT, Nurminskaya M, Belkin AM, Colak G, Johnson GV, Mehta K. Eckert RL, et al. Among authors: johnson gv. Physiol Rev. 2014 Apr;94(2):383-417. doi: 10.1152/physrev.00019.2013. Physiol Rev. 2014. PMID: 24692352 Free PMC article. Review.

9

Inhibition or ablation of transglutaminase 2 impairs astrocyte migration.

Monteagudo A, Ji C, Akbar A, Keillor JW, Johnson GVW. Monteagudo A, et al. Biochem Biophys Res Commun. 2017 Jan 22;482(4):942-947. doi: 10.1016/j.bbrc.2016.11.137. Epub 2016 Nov 27. Biochem Biophys Res Commun. 2017. PMID: 27899316 Free PMC article.

10

The complex role of transglutaminase 2 in glioblastoma proliferation.

Gundemir S, Monteagudo A, Akbar A, Keillor JW, Johnson GVW. Gundemir S, et al. Neuro Oncol. 2017 Feb 1;19(2):208-218. doi: 10.1093/neuonc/now157. Neuro Oncol. 2017. PMID: 27591334 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

266 results

Search Page